Certara, Inc. (NASDAQ:CERT) Receives Average Rating of “Hold” from Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have earned an average rating of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $15.42.

CERT has been the topic of a number of analyst reports. TD Cowen initiated coverage on Certara in a research report on Thursday. They set a “buy” rating and a $16.00 price target on the stock. Robert W. Baird reduced their price target on Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Finally, Barclays reduced their price target on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 7th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Mackenzie Financial Corp acquired a new stake in Certara during the 4th quarter worth about $17,852,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Certara by 16.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,574 shares of the company’s stock worth $2,807,000 after acquiring an additional 37,870 shares during the period. Voloridge Investment Management LLC grew its holdings in Certara by 269.3% during the 4th quarter. Voloridge Investment Management LLC now owns 275,633 shares of the company’s stock worth $2,935,000 after acquiring an additional 201,003 shares during the period. Squarepoint Ops LLC grew its holdings in Certara by 62.7% during the 4th quarter. Squarepoint Ops LLC now owns 94,433 shares of the company’s stock worth $1,006,000 after acquiring an additional 36,386 shares during the period. Finally, Two Sigma Advisers LP grew its holdings in Certara by 35.7% during the 4th quarter. Two Sigma Advisers LP now owns 87,500 shares of the company’s stock worth $932,000 after acquiring an additional 23,000 shares during the period. 73.96% of the stock is owned by institutional investors.

Certara Trading Down 0.4 %

Shares of NASDAQ:CERT opened at $12.33 on Thursday. The company has a market capitalization of $1.98 billion, a P/E ratio of -61.65, a P/E/G ratio of 9.29 and a beta of 1.57. Certara has a 1 year low of $9.41 and a 1 year high of $19.87. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The business’s 50 day simple moving average is $12.39 and its 200 day simple moving average is $11.63.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.